All posts by: Michael Zand

About Michael Zand

The UK’s NICE Recommends GSK’s €594000 Gene Therapy – Labiotech.eu (blog)

Continue reading

2017-10-25 NEWS

Labiotech.eu (blog)

The UK’s NICE Recommends GSK’s €594000 Gene Therapy
Labiotech.eu (blog)
Amidst uncertainty about the commercial future of expensive gene therapies, the UK’s NICE has declared GSK’s Strimvelis offers “value for money.” Approved by the EMA last year, Strimvelis is one of the most expensive drugs on the market. Although GSK

Continue reading

2017-10-25 NEWS

Dove Medical Press

Hematopoietic stem cell transplantation in a severe refractory Crohn’s disease patient with intestinal stoma: a case
Dove Medical Press
Background: Hematopoietic stem cell transplantation (HSCT) can be used in the treatment of patients with refractory Crohn’s disease (CD) when no alternative treatment is available. However, HSCT increases the risk of infections, in particular during

Continue reading

2017-10-24 NEWS

NBC 6 South Florida

Local 4-Year-Old Boy’s Cancer in Remission After Experimental Stem Cell Treatment at UM
NBC 6 South Florida
The Flash is the favorite superhero of 4-year-old Jovon Moss, who is his mother’s real-life hero as he is fighting a rare form of lymphoma through an experimental stem cell treatment. Jovon is being treated in the Alex’s Place pediatric center that’s
Stem cell therapy combats a one-in-a-million immune disorder for 4-year-old boyMiami Herald

all 2 news articles »

Continue reading

2017-10-24 NEWS

NBC 6 South Florida

Local 4-Year-Old Boy’s Cancer in Remission After Experimental Stem Cell Treatment at UM
NBC 6 South Florida
The Flash is the favorite superhero of 4-year-old Jovon Moss, who is his mother’s real-life hero as he is fighting a rare form of lymphoma through an experimental stem cell treatment. Jovon is being treated in the Alex’s Place pediatric center that’s
Stem cell therapy combats a one-in-a-million immune disorder for 4-year-old boyMiami Herald

all 2 news articles »

Continue reading

2017-10-24 NEWS

Lonza – Your Partner in Immunotherapy Research
The Scientist
Lonza is committed to supporting your immunotherapy research by providing primary cells, media and both large- and small-volume transfection solutions to help your transition from research into therapy. If you’re ready for the clinic, our cell therapy

and more »